Booster vaccine for measles, mumps, rubella, and chickenpox in children 4 to 6
Part of Infections, Mouth & dental clinical trials.
This study tests a combined booster vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6. It aims to see how well the vaccine boosts the immune system and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 4 and 6 years old (from 4th birthday up to the day before 7th birthday).
- Child has already had one dose of chickenpox vaccine and one dose of MMR vaccine during their second year of life (between 12 and 24 months old).
- Child has already had 3 or 4 doses of a DTP vaccine (diphtheria, tetanus, pertussis) according to local guidelines.
- Child is generally healthy with no serious medical conditions.
- Child has not had measles, mumps, rubella, chickenpox, or shingles in the past.
- Child has not had a second dose of chickenpox, MMR, or DTP after the second birthday.
- Child cannot have certain allergies (e.g., to neomycin, gelatin, latex) or immune system problems.
- No other vaccines or investigational drugs within 30 days before or during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
This trial tests a live chickenpox vaccine given at the same time as the MMR or DTaP shot for children ages 18 to 24 months. It may help protect your child from chickenpox while keeping their regular vaccine schedule on track.
This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.
This study tests a lower-dose varicella (chickenpox) vaccine in healthy children. It aims to see if the vaccine works and is safe. Your child may be able to join if they haven't had chickenpox or the vaccine before.
This trial is testing a second dose of the chickenpox vaccine in healthy children who already received one dose. It aims to see if a booster dose provides better protection.
This trial tests a chickenpox vaccine in healthy children ages 1 to 12 to see how well it works and if it's safe. If your child has never had chickenpox or the vaccine, or had one dose at least 3 months ago, they may be able to join.
Hear when a new Measles trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.